Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
Showing 6,001 - 6,020 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((mean decrease) OR (greater decrease)) ))', query time: 0.64s Refine Results
  1. 6001
    The proportion of neutrophils in SIC according to different algorithms.

    The proportion of neutrophils in SIC according to different algorithms. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 6002
    Confirmation of NMIIC expression.

    Confirmation of NMIIC expression. by Hiroki Hamaguchi (22783780)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 6003
    Cox model of LASSO model gene.

    Cox model of LASSO model gene. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 6004
    Key module genes.

    Key module genes. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 6005
    Univariate and multivariate Cox analysis.

    Univariate and multivariate Cox analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 6006
    Impact of PAC dosage on HPST.

    Impact of PAC dosage on HPST. by Peng Zhao (128233)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 6007
    The proportions of immune cells based on the MCP algorithm.

    The proportions of immune cells based on the MCP algorithm. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 6008
    WGCNA selection of SIC disease-related modules co-expressed genes.

    WGCNA selection of SIC disease-related modules co-expressed genes. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 6009
    Task design for measurement of pupillary response.

    Task design for measurement of pupillary response. by Tomoe Hayakawa (20978784)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 6010
    Experimental validation.

    Experimental validation. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 6011
    Frequency of hypoglycemic episodes in group 1 vs group 2.

    Frequency of hypoglycemic episodes in group 1 vs group 2. by Nadia Gul (249538)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 6012
    Line graph showing the trends of ADCs and NADCs with CD4 counts.

    Line graph showing the trends of ADCs and NADCs with CD4 counts. by Raymond Atwine (18574812)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 6013
    Demographics and baseline characteristics of patients.

    Demographics and baseline characteristics of patients. by Nadia Gul (249538)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 6014
    GO and KEGG analysis.

    GO and KEGG analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 6015
    S3 Fig -

    S3 Fig - by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 6016
    KEGG enrichment analysis.

    KEGG enrichment analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 6017
    GSEA results.

    GSEA results. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 6018
    GO enrichment analysis.

    GO enrichment analysis. by Wan-Jing Zhen (20427813)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 6019
    37%, 63%, and 100% amplitude (mm) and latency (ms).

    37%, 63%, and 100% amplitude (mm) and latency (ms). by Tomoe Hayakawa (20978784)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 6020
    Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration.

    Impact of group 1 and group 2 drugs on hyperglycemia based on HbA1c levels before and after 3 months of administration. by Nadia Gul (249538)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: